Garlic (Allium sativum L.) is a popular spice that has been widely used for thousands of years in traditional medicine. Several organosulfur compounds in garlic have been linked to its beneficial effects on health. Evidence from preclinical studies and clinical trials supports garlic's antihypertensive, antidiabetic, antiobesity, and hypolipidemic effects. This study aims to summarize clinical trial evidence regarding the effects of garlic on metabolic diseases and its mechanisms of action.
Get full access to this article
View all access options for this article.
References
1.
JiangTA: Health benefits of culinary herbs and spices. J AOAC Int, 2019; 102:395–411.
2.
ChoudharyPR, JaniRD, SharmaMS: Effect of raw crushed garlic (Allium sativum L.) on components of metabolic syndrome. J Diet Suppl, 2018; 15:499–506.
3.
ShangA, CaoSY, XuXY, et al.: Bioactive compounds and biological functions of garlic (Allium sativum L.). Foods, 2019; 8:246.
4.
YangC, LiL, yangL, Lü H, Wang S, Sung G: Anti-obesity and hypolipidemic effects of garlic oil and onion oil in rats fed a high-fat diet. Nutr metab (Lond), 2018; 15:43.
5.
PutnikP, GabricD, RoohinejadS, BarbaFJ, GranatoD, MallikarjunanK, LorenzoJM, KovacevicDB: An overview of organosulfur compounds from Allium spp.: From processing and preservation to evaluation of their bioavailability, antimicrobial, and ani-inflammatory properties. Food chem, 2019; 276:680–691.
6.
AsemaniY, ZamaniN, BayatM, AmirghofranZ: Allium vegetables for possible future of cancer treatment. Phytother Res, 2019; 3312:3019–3039.
7.
BisenPS, EmeraldM: Nutritional and therapeutic potential of garlic and onion (Allium sp.). Curr Nutr Food Sci, 2016; 12:190–199.
8.
PareekS, DixitM, GovilS, JadhavI, ShrivastavaD, VahediM, BisenPS: Garlic and its role in arthritis management. In: Bioactive Food as Dietary Interventions for Arthritis and Related Inflammatory Diseases, 2nd ed. (Watson RR and Preedy VR, eds.). England: Academic Press, 2019, pp. 245–252.
9.
SobeninIA, AndrianovaIV, FomchenkovIV, GorchakovaTV, OrekhovAN: Time-released garlic powder tablets lower systolic and diastolic blood pressure in men with mild and moderate arterial hypertension. Hypertens Res, 2009; 32:433–437.
10.
RiedK, TravicaN, SaliA: The effect of kyolic aged garlic extract on gut microbiota, inflammation, and cardiovascular markers in hypertensives: The GarGIC trial. Front Nutr, 2018; 5:122.
11.
RiedK, TravicaN, SaliA: The effect of aged garlic extract on blood pressure and other cardiovascular risk factors in uncontrolled hypertensives: The AGE at heart trial. Integr Blood Press Control, 2016; 9:9–21.
12.
ShoshiSJ, AkterH: Effects of garlic (Allium sativum) on blood glucose level in type 2 diabetes mellitus patients treated with metformin. J Enam Med Coll, 2017; 7:151–155.
13.
ManafikhiR, KalieL, LahdoR: Effects of garlic supplementation on fasting blood sugar, HbA1c and lipid profile in type 2 diabetics receiving metformin and glyburide. IJASR J, 2015; 3:11–18.
14.
KumarR, ChhatwalS, AroraS, et al.: Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase-lowering effects of garlic in patients with type 2 diabetes mellitus with obesity. Diabetes Metab Syndr Obes, 2013; 6:49–56.
15.
BordiaA: Effect of garlic on blood lipids in patients with coronary heart disease. Am J Clin Nutr, 1981; 34:2100–2013.
16.
JainAK, VargasR, GotzokowskyS, McMahonFG: Can garlic reduce levels of serum lipids? a controlled clinical study. Am J Med, 1993; 94:632–635.
SoleimaniD, PaknahadZ, AskariG, IrajB, FeiziA: Effect of garlic powder consumption on body composition in patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial. Adv Biomed Res, 2016; 5:1–10.
19.
AslaniN, EntezariMH, AskariG, MaghsoudiZ, MaracyMR: Effect of garlic and lemon juice mixture on lipid profile and some cardiovascular risk factors in people 30–60 years old with moderate hyperlipidaemia: A randomized clinical trial. Int J Prev Med, 2016; 7:95–103.
20.
RossierBC, BochudM, DevuystO: The hypertension pandemic: An evolutionary perspective. Physiology, 2017; 32:112–125.
21.
TakashimaM, KanamoriY, KoderaY, MoriharaN, TamuraK: Aged garlic extract exerts endothelium-dependent vasorelaxant effect on rat aorta by increasing nitric oxide production. Phytomedicine, 2017; 24:56–61.
22.
ParkBM, ChaSA, KimHY, et al.: Fermented garlic extract decreases blood pressure through nitrite and sGC-cGMP-PKG pathway in spontaneously hypertensive rats. J Funct Foods, 2016; 22:156–165.
23.
Al-QattanKK, ThomsonM, Al-Mutawa'aS, Al-HajeriD, DrobiovaH, AliM: Nitric oxide mediates the blood-pressure lowering effect of garlic in the rat two-kidney, one-clip model of hypertension. J Nutr, 2006; 136:774S–776S.
24.
Kim-ParkS, KuDD: Garlic elicits a nitric oxide-dependent relaxation and inhibits hypoxic pulmonary vasoconstriction in rats. Clin Exp Pharmacol Physiol, 2000; 27:780–786.
25.
BenavidesGA, SquadritoGL, MillsRW, PatelHD, IsbellTS, PatelRP, Darley-UsmarVM, DoellerJE, KrausDW: Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci USA, 2007; 104:17977–17982.
26.
ColettaC, PapapetropoulosA, ErdelyiK, et al.: Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation. Proc Natl Acad Sci USA, 2012; 109:9161–9166.
CastroC, LorenzoAG, GonzalezA, CruzadoM: Garlic components inhibit angiotensin II-induced cell-cycle progression and migration: Involvement of cell-cycle inhibitor p27(Kip1) and mitogen-activated protein kinase. Mol Nutr Food Res, 2009; 54:781–787.
29.
SuetsunaK: Isolation and characterization of angiotensin I-converting enzyme inhibitor dipeptides derived from Allium sativum L (garlic). J Nutr Biochem, 1998; 9:415–419.
30.
UshijimaM, TakasimaM, KunimuraK, KoderaY, MoriharaN, TamuraK: Effects of S-1-propenylcysteine, a sulfur compound in aged garlic extract, on blood pressure and peripheral circulation in spontaneously hypertensive rats. J Pharm Pharmacol, 2018; 70:559–565.
31.
NakasoneY, NakamuraY, YamamotoT, YamaguchiH: Effect of a traditional Japanese garlic preparation on blood pressure in prehypertensive and mildly hypertensive adults. Exp Ther Med, 2013; 5:399–405.
32.
RiedK, FrankOR, StocksNP: Aged garlic extract reduces blood pressure in hypertensives: A dose-response trial. Eur J Clin Nutr, 2013; 67:64–70.
33.
RiedK, FrankOR, StocksNP: Aged garlic extract lowers blood pressure in patients with treated but uncontrolled hypertension: A randomised controlled trial. Maturitas, 2010; 6:144–150.
34.
GruenwaldJ, BongartzU, BotheG, UebelhackR: Effects of aged garlic extract on arterial elasticity in a placebo-controlled clinical trial using EndoPAT™ technology. Exp Ther Med, 2020; 19:1490–1499.
35.
American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care, 2013; 36Suppl 1:S67–S74.
36.
ThomsonM, Al-AminZM, Al-QattanKK, ShabanLH, AliM: Anti-diabetic and hypolipidaemic properties of garlic (Allium sativum) in streptozotocin-induced diabetic rats. Int J Diabetes Metab, 2007; 15:108–115.
37.
BanerjeeSK, MaulikSK: Effect of garlic on cardiovascular disorders: A review. Nutr J, 2002; 1:1–14.
38.
RizwanAMP, RafeeqAK, ImranA: Effects of garlic on blood glucose levels and HbA1c in patients with type 2 diabetes mellitus. J Med Plants Res, 2011; 5:2922–2928.
39.
BanerjeeSK, MukherjeePK, MaulikSK: Garlic as an antioxidant: The good, the bad and the ugly. Phytother Res, 2003; 17:97–106.
40.
AnsaryJ, Forbes-HernándezTY, GilE, et al.: Potential health benefit of garlic based on human intervention studies: A brief overview. Antioxidants, 2020; 9:619–650.
41.
ObohG, AdemiluyiAO, AgunloyeOM, AdemosunAO, OgunsakinBG: Inhibitory effect of garlic, purple onion, and white onion on key enzymes linked with type 2 diabetes and hypertension. J Diet Suppl, 2019; 16:105–118.
42.
SobeninIA, NedosugovaLV, FilatovaLV, BalabolkinMI, GorchakovaTV, OrekhovAN: Metabolic effects of time-released garlic powder tablets in type 2 diabetes mellitus: The results of double-blinded placebo-controlled study. Acta Diabetol, 2008; 45:1–6.
43.
AtkinM, LaightD, CummingsMH: The effects of garlic extract upon endothelial function, vascular inflammation, oxidative stress and insulin resistance in adults with type 2 diabetes at high cardiovascular risk. A pilot double blind randomized placebo controlled trial. J Diabetes Complications, 2016; 30:723–727.
44.
SangouniAA, Mohammad Hosseini AzarMR, AlizadehM: Effects of garlic powder supplementation on insulin resistance, oxidative stress, and body composition in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial. Complement Ther Med, 2020; 51:102428.
45.
RudkowskaI: Lipid lowering with dietary supplements: Focus on diabetes. Maturitas, 2012; 72:113–116.
46.
National Library of Medicine: Pubmed MeSH. United States of America: National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/mesh?cmd=HistorySearch&querykey=12006 (accessed September11, 2020).
47.
KopinL, LowensteinC: Dyslipidemia. Ann Intern Med, 2017; 167:ITC81–ITC96.
48.
QuesadaI, de PaolaM, Torres-PalazzoloC, et al.: Effect of garlic's active constituents in inflammation, obesity and cardiovascular disease. Curr Hypertens Rep, 2020; 22:6.
49.
ZhangM, PanH, XuY, WangW, QiuZ, JiangL: allicin Decreases lipopolysaccharide-induced oxidative stress and inflammation in human umbilical vein endothelial cells through suppression of mitochondrial dysfunction and activation of Nrf2. Cell Physiol Biochem, 2017; 41:2255–2267.
50.
SendlA, SchliackM, LöserR, StanislausF, WagnerH: Inhibition of cholesterol synthesis in vitro by extracts and isolated compounds prepared from garlic and wild garlic. Atherosclerosis, 1992; 94:79–85.
51.
GebhardtR, BeckH: Differential inhibitory effects of garlic-derived organosulfur compounds on cholesterol biosynthesis in primary rat hepatocyte cultures. Lipids, 1996; 31:1269–1276.
52.
SpigelskiD, JonesPJ: Efficacy of garlic supplementation in lowering serum cholesterol levels. Nutr Rev, 2001; 59:236–241.
53.
SinghDK, PorterTD: Inhibition of sterol 4α-methyl oxidase is the principal mechanism by which garlic decreases cholesterol synthesis. J Nutr, 2006; 136:759S–764S.
54.
HunterPM, HegeleRA: Functional foods and dietary supplements for the management of dyslipidemia. Nat Rev Endocrinolm, 2017; 13:278–288.
55.
LauBHS: Suppression of LDL oxidation by garlic compounds is a possible mechanism of cardiovascular health benefit. J Nutr, 2006; 136:765S–768S.
56.
ZengT, GuoFF, ZhangCL, SongFY, ZhaoXL, XieKQ: A meta-analysis of randomized, double-blind, placebo-controlled trials for the effects of garlic on serum lipid profiles. J Sci Food Agric, 2012; 92:1892–1902.
57.
SunYE, WangW, QinJ: Anti-hyperlipidemia of garlic by reducing the level of total cholesterol and low-density lipoprotein A meta-analysis. Medicine, 2018; 97:e0255.
58.
SahebkarA, SerbanC, UrsoniuS, BanachM: Effect of garlic on plasma lipoprotein(a) concentrations: A systematic review and meta-analysis of randomized controlled clinical trials. Nutrition 2016;32:33–40.
59.
RiedK: Garlic lowers blood pressure in hypertensive individuals, regulates serum cholesterol, and stimulates immunity: An updated meta-analysis and review. J Nutr, 2016; 146:389S–396S.
60.
ShabaniE, SayemiriK, MohammadpourM: The effect of garlic on lipid profile and glucose parameters in diabetic patients: A systematic review and meta-analysis. Prim Care Diabetes, 2019; 13:28–42.
61.
AdlerAJ, HolubBJ: Effect of garlic and fish-oil supplementation on serum lipid and lipoprotein concentrations in hypercholesterolemic men. Am J Clin Nutr, 1997; 65:445–450.
62.
SobeninIA, PryanishnikovVV, KunnovaLM, RabinovichYA, MartirosyanDM, OrekhovAN: The effects of time-released garlic powder tablets on multifunctional cardiovascular risk in patients with coronary artery disease. Lipids Health Dis, 2010; 9:119.
63.
JungES, ParkSH, ChoiEK, et al.: Reduction of blood lipid parameters by a 12-wk supplementation of aged black garlic: A randomized controlled trial. Nutrition, 2014; 30:1034–1039.
64.
ConwayB, ReneA: Obesity as a disease: No lightweight matter. Obes Rev, 2004; 5:145–151.
65.
KimY, LeeMS, KimJS, LeeHS: Garlic decreases body weight via decrease of serum lipid and increase of uncoupling proteins mRNA expression. FASEB J, 2007; 21:LB59.
66.
JooH, KimCT, KimIH, KimY: Anti-obesity effects of hot water extract and high hydrostatic pressure extract of garlic in rats fed a high-fat diet. Food Chem Toxicol, 2013; 55:100–105.
67.
KeophiphathM, PriemF, Jacquemond-ColletI, ClémentK, LacasaD: 1,2-vinyldithiin from garlic inhibits differentiation and inflammation of human preadipocytes. J Nutr, 2009; 139:2055–2060.
68.
YangJY, Della-FeraMA, Nelson-DooleyC, BaileCA: Molecular mechanisms of apoptosis induced by ajoene in 3T3-L1 adipocytes. Obesity, 2006; 14:388–397.
69.
KimEJ, LeeDH, KimHJ, et al.: Thiacremonone, a sulfur compound isolated from garlic, attenuates lipid accumulation partially mediated via AMPK activation in 3T3-L1 adipocytes. J Nutr Biochem, 2012; 23:1552–1558.
70.
SeoDY, LeeSR, KimHK, et al.: Independent beneficial effects of aged garlic extract intake with regular exercise on cardiovascular risk in postmenopausal women. Nutr Res Pract, 2012; 6:226–231.
71.
SharifiF, SheikhiA, BehdadM, MousavinasabS: Effect of garlic on serum adiponectin and interleukin levels in women with metabolic syndrome. Int J Endocrinol Metab, 2010; 8:68–73.
72.
XuC, MathewsAE, RodriguesC, et al.: Aged garlic extract supplementation modifies inflammation and immunity of adults with obesity: A randomized, double-blind, placebo-controlled clinical trial. Clin Nutr ESPEN, 2018; 24:148–155.
73.
McCrackenE, MonaghanM, SreenivasanS: Pathophysiology of the metabolic syndrome. Clin Dermatol, 2018; 36:14–20.
74.
SangouniAA, AlizadehM, JamalzehiA, ParastoueiK: Effects of garlic powder supplementation on metabolic syndrome components, insulin resistance, fatty liver index, and appetite in subjects with metabolic syndrome: A randomized clinical trial. Phytother Res, 2021; 35:4433–4441.
75.
Gómez-ArbeláezD, LaheraV, OubiñaP, et al.: Aged garlic extract improves adiponectin levels in subjects with metabolic syndrome: A double-blind, placebo-controlled, randomized, crossover study. Mediators Inflamm, 2013; 2013:285795.
